Piperidines
Medchemexpress LLC Piperidine-4-carboxamide-d9 | 1219803-20-9 | 98.2% | 137.23 | 5 MG
Piperidine-4-carboxamide-d9 is the deuterium labeled Piperidine-4-carboxamide. It is for research use only. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs.
- Used as a tracer
- Used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS
eMolecules 138007-24-6 | tert-Butyl piperidine-4-carboxylate | Combi-Blocks | MFCD02684429 | 185.267 | C10H19NO2 | 98.000 | CC(C)(C)OC(=O)C1CCNCC1 | 5g | 303354731
tert-Butyl piperidine-4-carboxylate | Combi-Blocks | 138007-24-6 | MFCD02684429 | 185.267 | C10H19NO2 | 98.000 | CC(C)(C)OC(=O)C1CCNCC1 | 5g | 303354731
eMolecules 183673-71-4 | 4-Amino-1-Boc-piperidine-4-carboxylic acid | Oakwood Chemicals | MFCD01318728 | 244.291 | C11H20N2O4 | 97.000 | CC(C)(C)OC(=O)N1CCC(N)(CC1)C(O)=O | 1g | 480120627
4-Amino-1-Boc-piperidine-4-carboxylic acid | Oakwood Chemicals | 183673-71-4 | MFCD01318728 | 244.291 | C11H20N2O4 | 97.000 | CC(C)(C)OC(=O)N1CCC(N)(CC1)C(O)=O | 1g | 480120627
eMolecules 138007-24-6 | tert-Butyl piperidine-4-carboxylate | ChemScene | MFCD02684429 | 185.267 | C10H19NO2 | 97.000 | CC(C)(C)OC(=O)C1CCNCC1 | 25g | 801484239
tert-Butyl piperidine-4-carboxylate | ChemScene | 138007-24-6 | MFCD02684429 | 185.267 | C10H19NO2 | 97.000 | CC(C)(C)OC(=O)C1CCNCC1 | 25g | 801484239
eMolecules 84358-13-4 | N-Boc-piperidine-4-carboxylic acid | Combi-Blocks | MFCD00076999 | 229.276 | C11H19NO4 | 98.000 | CC(C)(C)OC(=O)N1CCC(CC1)C(O)=O | 1kg | 290684670
N-Boc-piperidine-4-carboxylic acid | Combi-Blocks | 84358-13-4 | MFCD00076999 | 229.276 | C11H19NO4 | 98.000 | CC(C)(C)OC(=O)N1CCC(CC1)C(O)=O | 1kg | 290684670
Medchemexpress LLC Piperidine-4-sulfonic acid | 72450-62-5 | MFCD00055097 | C5H11NO3S | 10MG
Piperidine-4-sulfonic acid is a small-molecule research reagent that acts as a potent GABA receptor agonist used to probe GABAergic binding and function in in vitro neuroscience studies. It is supplied as a high-purity solid with supporting analytical and safety documentation for laboratory research use.
- Potent GABA receptor agonist with reported IC50 = 0.034 μM for inhibition of H-GABA binding.
- High purity (99.95%) suitable for analytical and biological assays.
- Molecular formula C5H11NO3S and molecular weight 165.21 g·mol⁻¹.
- Intended for in vitro research use only.
- Provided with RP-HPLC purity profile and safety data sheet.
eMolecules 161491-24-3 | 4-Oxo-piperidine-1,3-dicarboxylic acid 1-tert-butyl ester 3-methyl ester | J & W PharmLab LLC | MFCD08752608 | 257.286 | C12H19NO5 | 96.000 | COC(=O)C1CN(CCC1=O)C(=O)OC(C)(C)C | 25g | 292816281
4-Oxo-piperidine-1,3-dicarboxylic acid 1-tert-butyl ester 3-methyl ester | J & W PharmLab LLC | 161491-24-3 | MFCD08752608 | 257.286 | C12H19NO5 | 96.000 | COC(=O)C1CN(CCC1=O)C(=O)OC(C)(C)C | 25g | 292816281
eMolecules 87120-72-7 | 4-Amino-1-Boc-piperidine | J & W PharmLab, LLC | MFCD01076201 | 200.282 | C10H20N2O2 | 96.000 | CC(C)(C)OC(=O)N1CCC(N)CC1 | 25g | 249985614
4-Amino-1-Boc-piperidine | J & W PharmLab, LLC | 87120-72-7 | MFCD01076201 | 200.282 | C10H20N2O2 | 96.000 | CC(C)(C)OC(=O)N1CCC(N)CC1 | 25g | 249985614
eMolecules 183673-71-4 | 4-Amino-1-Boc-piperidine-4-carboxylic acid | Ambeed | MFCD01318728 | 244.291 | C11H20N2O4 | 97.000 | CC(C)(C)OC(=O)N1CCC(N)(CC1)C(O)=O | 5g | 490553784
4-Amino-1-Boc-piperidine-4-carboxylic acid | Ambeed | 183673-71-4 | MFCD01318728 | 244.291 | C11H20N2O4 | 97.000 | CC(C)(C)OC(=O)N1CCC(N)(CC1)C(O)=O | 5g | 490553784
![Medchemexpress LLC 3-[1-[(3S)-1-prop-2-enoylpyrrolidin-3-yl]oxyisoquinolin-3-yl]-1,4-dihydro-1,2,4-triazol-5-one | 1627603-21-7 | 99.9% | C18H17N5O3 | 10MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000260119.png-250.jpg)
Medchemexpress LLC 3-[1-[(3S)-1-prop-2-enoylpyrrolidin-3-yl]oxyisoquinolin-3-yl]-1,4-dihydro-1,2,4-triazol-5-one | 1627603-21-7 | 99.9% | C18H17N5O3 | 10MG
TAK-020 is a covalent Bruton's tyrosine kinase (BTK) inhibitor developed by Takeda and advanced as a clinical candidate for hematologic malignancies and autoimmune diseases. It irreversibly binds Cys481 in BTK's ATP-binding site and is provided by research suppliers as a characterized small-molecule reagent (CAS 1627603-21-7).
- Covalent inhibitor that targets Cys481 in BTK.
- Selective BTK inhibition supported by preclinical and clinical data.
- Well-characterized small molecule with published analytical reports.
- Available from vendors in mg-scale quantities for research use.
- Typically supplied as high-purity material for in vitro and in vivo studies.
eMolecules 97231-90-8 | Benzyl piperidine-3-carboxylate | MFCD14611752 | 1g
Ambeed | Benzyl piperidine-3-carboxylate | 1g | 525190036 | A336575 | 97231-90-8 | MFCD14611752 | 219.284 | C13H17NO2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>